Time to sepsis treatment and survival
Across tens of thousands of patients under a mandated sepsis protocol, longer time to completing the treatment bundle, and to antibiotics, was associated with higher mortality.
What the study found
This 2017 New England Journal of Medicine study analyzed more than 49,000 patients treated under New York State's mandated sepsis-care protocol. Hospitals had to complete a three-hour "bundle" — drawing blood cultures, giving broad-spectrum antibiotics, and measuring blood lactate. Longer time to completing the bundle, and longer time to antibiotics specifically, were each associated with higher in-hospital mortality, with the risk rising for every additional hour of delay.
Why it matters
Sepsis is a dysregulated, body-wide response to infection that can cause organ failure quickly, and debate had long swirled over whether rigid time targets actually help or just create paperwork. A very large, real-world dataset lent weight to the idea that starting antibiotics early saves lives.
Analysis — the pattern
This fits a recurring infection-care theme (analysis): much of the survival gain comes from reliable, fast execution of already-known steps — bundles, checklists, early antibiotics — rather than from new drugs, echoing the central-line and sepsis-bundle literature. It does not tell clinicians to skip careful diagnosis; it argues for systems that recognize sepsis and act without delay. An open tension is speeding treatment without driving antibiotic overuse and resistance.
What is still uncertain
This was an observational analysis, so it shows association, not proof of cause. The ideal time targets, how strictly to define sepsis, which patients the targets fit best, and how to balance speed against antibiotic stewardship all remain debated.